Intravenous Alpha-1 Antitrypsin Therapy for Critically III COVID-19 Patients

Ori Wand, David Dahan, Naveh Tov, Gali Epstein Shochet, Daniel A. King, David Shitrit

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)441-443
Number of pages3
JournalIsrael Medical Association Journal
Volume24
Issue number7
StatePublished - 1 Jul 2022

Keywords

  • alpha-1 antitrypsin (AAT)
  • coronavirus disease 2019 (COVID-19)
  • intensive care unit (ICU)
  • severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • ventilation

Cite this